Development and evaluation of miltefosine-loaded nanoemulsions on in vitro culture of Toxoplasma gondii

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 137

فایل این مقاله در 15 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_NAMJ-11-2_006

تاریخ نمایه سازی: 27 اسفند 1402

چکیده مقاله:

Objective(s): Toxoplasma gondii is a common parasite in the world. Pharmaceutical options for toxoplasmosis treatment are limited. Several studies have been conducted on the anti-infectious properties of miltefosine (MLF). We investigated the effectiveness of nanoemulsion miltefosine (NEM) in tachyzoites of T. gondii, RH strain.Materials and Methods: Various NEM formulations were designed considering pseudo-ternary phase diagrams. Physicochemical properties of the developed nanoemulsions (NEs), including pH, polydispersity index (PDI), droplet size, and refractive index (RI) were evaluated. The considered formulation was analyzed for dilution and stability tests. MTT assay was performed on Vero cells for calculation CC۵۰ and on Vero cells with RH strain tachyzoite for calculation IC۵۰. Sulfadiazine (SDZ) and pyrimethamine (PYR) were positive controls. The trypan blue method was used to investigate the effect of drugs (NEM, MLF, SDZ, PYR) in reducing the number of infected Vero cells and reducing the intracellular proliferation of tachyzoites. Next, the viability of tachyzoites was measured in the tube in the direct vicinity of different drug concentrations.Results: The final particle size of NEM was calculated to be ۱۷.۴۶۳ nm by DLS and TEM. The CC۵۰ of NEM (۷۵.۷ µg/mL) indicated lower toxicity than the other drugs. IC۵۰ obtained by trypan blue, MTT, and test tube methods showed that NEM (۲۸.۴۳ µg/mL) has a suitable IC۵۰ against Toxoplasma tachyzoites.Conclusion: The calculated selectivity index (SI) demonstrated that NEM (SI=۲.۶۶) is a more suitable drug candidate than the MLF and positive controls. The trypan blue assay indicated the excellent reduction effect of NEM on T. gondii intracellular proliferation rate and the number of infected cells.

نویسندگان

Gholam Valizadeh

Department of Parasitology and Mycology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Mohammad Mahboobian

Department of Pharmaceutics, Faculty of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran

Amir Maghsood

Department of Parasitology and Mycology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Fatemeh Mirzaei

Department of Anatomy, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Seyedmousa Motavallihaghi

Department of Parasitology and Mycology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Faezeh Foroughi Parvar

Department of Parasitology and Mycology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Mohammad Fallah

Department of Parasitology and Mycology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. ۲۰۰۴;۳۶۳(۹۴۲۵):۱۹۶۵-۱۹۷۶ ...
  • Montazeri M, Sharif M, Sarvi S, Mehrzadi S, Ahmadpour E, ...
  • Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: ...
  • Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, ...
  • Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug ...
  • Gupta A, Eral HB, Hatton TA, Doyle PS. Nanoemulsions: formation, ...
  • Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Nanoemulsion as ...
  • Gutiérrez J, González C, Maestro A, Sole I, Pey C, ...
  • van Blitterswijk WJ, Verheij M. Anticancer alkylphospholipids: mechanisms of action, ...
  • Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ. Miltefosine: ...
  • Llull D, Rivas L, García E. In vitro bactericidal activity ...
  • Widmer F, Wright LC, Obando D, Handke R, Ganendren R, ...
  • Chugh P, Bradel-Tretheway B, Monteiro-Filho CM, Planelles V, Maggirwar SB, ...
  • Eissa MM, El-Azzouni MZ, Amer EI, Baddour NM. Miltefosine, a ...
  • Blaha C, Duchêne M, Aspöck H, Walochnik J. In vitro ...
  • Eissa MM, Amer EI. Giardia lamblia: A new target for ...
  • Seifert K, Duchêne M, Wernsdorfer WH, Kollaritsch H, Scheiner O, ...
  • Walochnik J, Duchêne M, Seifert K, Obwaller A, Hottkowitz T, ...
  • Polat ZA, Obwaller A, Vural A, Walochnik J. Efficacy of ...
  • Schuster FL, Guglielmo BJ, Visvesvara GS. In-vitro activity of miltefosine ...
  • Garg R, Tremblay MJ. Miltefosine represses HIV-۱ replication in human ...
  • Ni Nyoman AD, Lüder CG. Apoptosis-like cell death pathways in ...
  • World Health Organization (۲۰۱۹). World Health Organization model list of ...
  • Eissa MM, Barakat AM, Amer EI, Younis LK. Could miltefosine ...
  • Mohammad Mehdi M, Seyed Mohsen F, Reza A. Brinzolamide-Loaded Nanoemulsions: ...
  • Shafiq S, Shakeel F. Stability and self-nanoemulsification efficiency of ramipril ...
  • Butani D, Yewale C, Misra A. Amphotericin B topical microemulsion: ...
  • Ebrahimzadeh MA, Taheri MM, Ahmadpour E, Montazeri M, Sarvi S, ...
  • Khamesipour F, Razavi SM, Hejazi SH, Ghanadian SM. In vitro ...
  • Montazeri M, Emami S, Asgarian-Omran H, Azizi S, Sharif M, ...
  • Coelho AC, Trinconi CT, Costa CH, Uliana SR. In vitro ...
  • Barbosa BF, Gomes AO, Ferro EA, Napolitano DR, Mineo JR, ...
  • Shah J, Nair AB, Jacob S, Patel RK, Shah H, ...
  • Fouad SA, Basalious EB, El-Nabarawi MA, Tayel SA. Microemulsion and ...
  • Garcia CR, Malik MH, Biswas S, Tam VH, Rumbaugh KP, ...
  • Chavhan SS, Petkar KC, Sawant KK. Simvastatin nanoemulsion for improved ...
  • Altaani BM, Almaaytah AM, Dadou S, Alkhamis K, Daradka MH, ...
  • Laxmi M, Bhardwaj A, Mehta S, Mehta A. Development and ...
  • Nemati S, Mohammad Rahimi H, Hesari Z, Sharifdini M, Jalilzadeh ...
  • Sanfelice R, Bortoleti B, Tomiotto-Pellissier F, Silva TF, Bosqui LR, ...
  • Azami SJ, Amani A, Keshavarz H, Najafi-Taher R, Mohebali M, ...
  • Adeyemi OS, Murata Y, Sugi T, Kato K. Inorganic nanoparticles ...
  • Arruda da Silva Sanfelice R, Silva TF, Tomiotto-Pellissier F, Bortoleti ...
  • Quan JH, Gao FF, Ismail H, Yuk JM, Cha GH, ...
  • نمایش کامل مراجع